MedTrace Logo

Digital Cognitive Behavior Therapy Program for Suicide Prevention

NCT03595254 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 725

Last updated 2020-09-02

No results posted yet for this study

Summary

This study evaluates the efficacy of Thrive, a computerized cognitive behavior therapy program, to reduce depression and anxiety symptoms and to reduce suicidal thinking among adults. The first 450 participants will participate in a randomized waitlist controlled trial. The remaining 550 participants will be provided the program immediately upon enrolling

Conditions

Interventions

BEHAVIORAL

Thrive

Computerized Cognitive Behavior Therapy program

Sponsors & Collaborators

  • Montana Department of Public Health and Human Services

    collaborator UNKNOWN

  • Montana State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-16
Primary Completion
2020-04-08
Completion
2020-04-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03595254 on ClinicalTrials.gov